The Impact of T Cells in Neurodegenerative Disease and Regenerative Therapies
![The Impact of T Cells in Neurodegenerative Disease and Regenerative Therapies](https://nationalstemcelltherapy.com/wp-content/uploads/2022/06/The-Impact-of-T-Cells-in-Neurodegenerative-Disease-and-Regenerative-Therapies-1024x576.jpg)
UCI Sue and Bill Gross Stem Cell Research Center Lecture by Craig Walsh, Ph.D. talking a little bit about the immune system and how particular types of cells of the immune system called T cells; the roles that they play in neurodegenerative diseases, and talk about multiple sclerosis and Alzheimer’s disease. And in particular how […]
TScan Therapeutics Presents Preclinical Data at the American Society of Gene and Cell Therapy 25th Annual Meeting
![TScan Therapeutics Logo](https://nationalstemcelltherapy.com/wp-content/uploads/2022/05/tscan-logo.png)
WALTHAM, Mass., May 19, 2022 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer, presented two posters and an oral presentation around TScan’s proprietary platform technologies for its solid tumor program at […]